Bhattacharjee et al. found no obvious changes in CD4+ CD25+ FoxP3+ T cell counts in patients with PV after monotherapy with rituximab, an anti-CD20 monoclonal antibody that could induce B cell depletion and is commonly used in autoimmune diseases (51, 52). Here, FOXP3 is linked to autoimmune disease.